Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease

Clinical trial NCT02172573 · COMPLETED

Trial details

NCT number: NCT02172573
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 1999-04-01
Primary completion: 2000-07-01
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.